Tissue Regenix Group plc Sustainability Profile
Tissue Regenix Group plc, a pioneering name in regenerative medicine, is headquartered in the United Kingdom. Founded in 2006, the company has established itself as a leader in the development of innovative tissue regeneration technologies, primarily focusing on orthopaedics and wound care. With a strong presence in Europe and North America, Tissue Regenix offers unique products such as dCELL® technology, which decellularises human and animal tissues to create scaffolds that promote natural healing. This approach not only enhances patient outcomes but also addresses the growing demand for effective regenerative solutions. Recognised for its commitment to advancing medical science, Tissue Regenix has achieved significant milestones, positioning itself as a key player in the regenerative medicine industry. The company continues to drive innovation, making strides in both product development and market expansion.
DitchCarbon Score
How does Tissue Regenix Group plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tissue Regenix Group plc's score of 26 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tissue Regenix Group plc's reported carbon emissions
Tissue Regenix Group plc, headquartered in Great Britain, currently does not have available data on its carbon emissions, including specific figures for Scope 1, Scope 2, or Scope 3 emissions. As a result, there are no reported total emissions figures or reduction targets at this time. The company has not disclosed any climate commitments or initiatives aimed at reducing carbon emissions. Without specific data or commitments, it is unclear how Tissue Regenix Group plc is addressing climate change within its operations or supply chain.
How Carbon Intensive is Tissue Regenix Group plc's Industry?
How Carbon Intensive is Tissue Regenix Group plc's Location?
Tissue Regenix Group plc's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tissue Regenix Group plc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Musculoskeletal Transplant Foundation
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.